Perrigo Company plc Foreign Currency Transaction Gain (Loss), Unrealized
Perrigo Company plc (PRGO) reported Foreign Currency Transaction Gain (Loss), Unrealized of $4 for the 3-month period ending 2013-09-28, per its 10-Q filed 2013-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2013-11-04
- Perrigo Company plc foreign currency transaction gain (loss), unrealized for the quarter ending 2013-09-28 was $4.00.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month |
|---|---|
| 2013-09-28 | $4.00 10-Q · filed 2013-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |